Choreo LLC Purchases 465 Shares of Waters Co. (NYSE:WAT)

Choreo LLC boosted its holdings in shares of Waters Co. (NYSE:WAT) by 21.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,610 shares of the medical instruments supplier’s stock after acquiring an additional 465 shares during the quarter. Choreo LLC’s holdings in Waters were worth $968,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Waters by 26.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 6,512 shares of the medical instruments supplier’s stock valued at $2,435,000 after purchasing an additional 1,379 shares in the last quarter. E. Ohman J or Asset Management AB raised its holdings in Waters by 19.9% during the fourth quarter. E. Ohman J or Asset Management AB now owns 2,834 shares of the medical instruments supplier’s stock valued at $1,051,000 after buying an additional 470 shares in the last quarter. Brown Lisle Cummings Inc. lifted its position in shares of Waters by 11.0% in the fourth quarter. Brown Lisle Cummings Inc. now owns 1,510 shares of the medical instruments supplier’s stock worth $560,000 after buying an additional 150 shares during the last quarter. Willis Investment Counsel lifted its position in shares of Waters by 3.1% in the fourth quarter. Willis Investment Counsel now owns 31,727 shares of the medical instruments supplier’s stock worth $11,770,000 after buying an additional 956 shares during the last quarter. Finally, Deroy & Devereaux Private Investment Counsel Inc. boosted its stake in shares of Waters by 0.3% during the 4th quarter. Deroy & Devereaux Private Investment Counsel Inc. now owns 9,610 shares of the medical instruments supplier’s stock worth $3,565,000 after acquiring an additional 30 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms recently weighed in on WAT. Deutsche Bank Aktiengesellschaft boosted their target price on Waters from $310.00 to $325.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Bank of America upped their price objective on shares of Waters from $400.00 to $430.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Barclays lifted their target price on shares of Waters from $330.00 to $360.00 and gave the stock an “underweight” rating in a report on Monday, November 4th. TD Cowen upped their price target on shares of Waters from $363.00 to $410.00 and gave the company a “hold” rating in a report on Monday, November 4th. Finally, JPMorgan Chase & Co. raised their price target on Waters from $340.00 to $380.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Waters has an average rating of “Hold” and an average target price of $384.71.

Waters Stock Performance

WAT opened at $408.96 on Monday. The stock’s 50 day simple moving average is $389.56 and its 200-day simple moving average is $362.42. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14. The stock has a market cap of $24.28 billion, a PE ratio of 39.02, a P/E/G ratio of 7.37 and a beta of 1.01. Waters Co. has a 1 year low of $279.24 and a 1 year high of $423.56.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.